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ABSTRACT 
Due to public pressure, in vivo methods of toxicity testing is being 
attempted to be replaced by in vitro methods, such as cell and organ 
culture, computer modelling and modified LDS0 tests using lesser 
number of animals. Specifically in the case of Draize eye imtancy test 
using rabbits, a number of refinements have- been incorporated by 
different workers, mainly use of a local anaesthetic which will reduce 
animal distress without vitiating the test results. The author 
recommends exploration of new avenues for testing based on the 
advances in cell biology. 
1. INTRODUCTION 
There is a societal need and responsibility for public authorities to attempt to 
ensure that individuals in society are protected from harmful effects of foreign 
substances. Given the current state of our knowledge, this necessitates some testing 
in animals and extrapolation of the results, no matter how difficult, to predict likely 
human responses. We are still far too ignorant to predict the toxic effects of a compound 
from first principles (via theoretical toxicology?). Therefore, we have to fall back on 
appropriate models of the human system to identify possible hazards. By necessity, 
this leads to the use of mammals or other species that often respond in a sufficiently 
similar manner to humans to provide an index of the potential hazard. 
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Nevertheless, the problems of extrapolation and evaluation are formidable. 
Thousands of new chemicals need to be evaluated every year while only a fraction of 
the estimated 65,000 chemicals1 in common use today have been subject to testing 
according to available public information.' In addition, the present animal testing 
technologies are generally crude, cumbersome and costly and there is growing public 
criticism of such use of animals. 
Among toxicologists, there are some who see animal testing as an unsatisfactory 
answer to toxicology's problems. Thus, in 1971, ~ o f e , ~  in an excellent but little-cited 
review of the use of tissue culture in toxicology, stated that: 
'In seeking to bridge the gap between the effects of foreign substances on 
animals and their effects on man, it seems unlikely that a substantial 
contribution to the problem can be made by prolonging the conventional 
toxicological procedures or including additional organ function tests'. 
Others,. scientific and non-scientific, have also criticized animal testing,19 
commenting variously that toxicology has, in the last decade, sometimes created more 
problem than it has solved, that toxicology is ascience without scientific underpinning, 
and that we should move towards the development of an appropriate battery of short 
term tests, using both in vitro and in vivo approaches, to assess product safety. 
The techniques most commonly hTghlighted as having potential for the future are 
cell and organ culture, computer modelling, and the use of less invasive animal 
procedures and endpoints producing little stress or suffering. There have already been 
a number of reviews of the use of cell and organ culture in toxicology investigations 
beginning with a seminal paper by Pomerat and Leake in 1954," followed by a number 
of reviews after However, judging from the number of citations to these 
papers, none have had impact. According to the records of the Science Citation Index, 
Rofe's 1971 review has been cited less than twenty times in the following 12 years 
with a high of three citations each in 1976 and 1980. Although more and more 
toxicological research is being conducted in vitro , the potential of cell culture, as 
applied to toxicological evaluation and hazard assessment, is only now beginning to 
be tested and assessed. This is the result of public pressure, the availability of funds 
for such studies, and increased concern apong scientists. 
However, the use of cell cultures must be cautiously developed and implemented 
in toxicology testing and hazard assessment. Obviously, a single cell culture cannot 
mimic all the complex interactions of all the cell types in the body no matter how 
exquisite the experimental design. In vivo metabolism may be simulated to some 
extent but not completely2' and other integrating functions (for example, hormones, 
immune reactions, phagoctytosis) are not included. In addition, a cell culture is a 
relatively static system in which the dose of the test chemical reaching the target 
system and the duration of contact may not be the same as those that occur in the in 
vivo tests. There are also physical problems regarding solubility, stability and 
biophysical effects of the test compound. 
On the other hand, the technique of cell culture has great potentiill once 
investigators have acquired the background knowledge to ask highly focused and 
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specific questions. The static nature of cell culture is also an advantage in that the 
dose and duration of contact of a test chemical can be precisely determined. Far less 
of the test chemical is required for cell culture investigations than in in viva tests. 
Therefore, one can set up replicate cultures with ease and generate more data in a 
short time. 
Ope of the most exciting aspects of cell culture studies in toxicology is that one 
can use human tissue. Such studies have been limited in the past because of the 
difficulty of maintaining and growing differentiated human cell types in culture. But, 
the technical problems are being steadily overcome. For example, important 
developments in the past years include improvements in the quality control of media 
and plasticware provided by manufacturers, improved quality control in the laboratory, 
better media  formulation^^^ for the growth of normal cells as well as for cells exhibiting 
specialized functions (for example, heart cell contractility and melanin production by 
melanocytes), and improvements in cell separation and cloning techniques.= 
Nardone and ~ r a d l a e  describe four interfaces between in vitro methodology 
and animal toxicology - screening tests, mechanistic studies, personnel monitoring 
and considerations for risk assessment. They note that screening tests are the most 
developed and are likely to remain the major focus of in ntro toxicology. However, 
mechanistic studies probably will become steadily more important, both in toxicological 
evaluations and for risk assessment. One could also classi£y in vitro methodology 
according to whether the approach is empirical, model development or mechanistic." 
The empirical approach for the development of methodology is problematic. The 
questions asked are generally not focused and the intent is to develop correlations 
prior to fundamental understandings. Additionally, the results tend to be somewhat 
unpredictable. Should this be the case in the development of in vitro toxicological 
methods we will have unfortunately provided supplementary testing strategies but not 
replacement testing strategies. This will leave us with the dilemma of attempting to 
use the in vitro methodologies without being able to rely on them. 
Model development attempts to utilize systems that mimic the in vivo systems. 
Generally, the model system is neither complete nor faithful in all aspects of the 
system being modeled, but it tends to provide useful information if the data are not 
over-interpreted. In those model systems where a single aspect of an integrated 
response is examined and the data are interpreted in that single system, it can provide 
meaningful inferences for the evaluation of chemical effects. 
The mechanistic approach in the development of in vitro methodologies should 
be based on a thorough knowledge of the metabolism, kinetics, and biology in the 
system or species to be examined. If the metabolic pathways are understood, or if it 
is known that the parent compound produces the toxicological insult, then one can 
develop a system to examine the mechanisms by which the chemical(s) works. That 
is, one can examine the adverse chemical or physical effects that lead to a significant 
functional loss in the tissue or system. This approach allows the in vitro system to be 
derived from the species under study. It also provides a better understanding of the 
chemical-biological interaction and the consequences of that interaction. Once a 
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mechanism has been identified it may then be possible to develop appropriate, 
interpretable, simple and reliable in vitro methodologies. 
From a scientific viewpoint, the mechanistic approach is not only preferable but 
necessary. In vitro methods will be more acceptable and will develop rapidly when 
the knowledge base has advanced far enough to permit a focus on mechanisms. 
2. ALTERNATIVES IN TOXICOLOGY 
Toxicity testing on animals may be divided into acute, subacute and chronic tests. 
Acute tests are those in which the animpls are dosed with one or a few doses of the 
test compound and kept for at most a few weeks. Such tests include protocols for 
determining the various LDSo's as well as eye and skin irritancy tests. Up to 50 per 
cent of all animals used in toxicology testing are killed in acute tests.25 Subchronic 
tests last from a few weeks to several months. Chronic tests last for more than three 
months and include tests for reproductive and carcinogenic effects among others. The 
search for new approaches in all these areas will continue to evolve. However, at 
present time, our lack of knowledge about the mechanisms of possible toxic insults 
is such that some animal testing is going to be required. 
2.1 Acute Toxidty Tating 
In acute tests, the investigator is observing an immediate response in which the 
organism's defence mechanisms are rapidly overwhelmed. Where specific end-points 
are being determined (for example, eye imtancy) it may well be possible to develop 
an adequate in vitro alternative based on one or more screening systems. However, 
one of the functions of acute testing is the identification of unexpected toxic effects. 
The empiricism of this approach requires that a relatively good model for the whole 
human being be used. This generally means using a whole mammal because the 
metabolism and response of other mammals is at least sufficiently similar to human 
responses to provide an index of hazard. However, there are acute tests for which 
the prospect of either reducing the number of animals used, or for developing an 
adequate in vitro tests are relatively good and these are discussed below. 
2.1.1 LD5, testing 
The calculation of the median lethal dose LDM for the measurement of toxicity 
was introduced26 in 1927. At that time, determination of the LDM was used to 
standardize such potent biologicals as digitalis, insulin and diphtheria toxin. With 
time, however, the LDSo came to be used as a standard measure by which the toxicity 
of all chemicals was assessed. In 1968, Momson, Quinton and Reinert questioned 
this use2' of the LDS0, arguing that the classical test used too many animals and that 
the statistical figure resulting was quite meaningless. They contended that a figure, 
generated from the use of 6-10 animals, was the best that could be achieved given 
the inadequacies of the test system.28 There have been several recent criticisms29J' of 
the LDS0. AS a result of scientific criticism, coupled with political pressure from the 
Conceptual Approaches in Toxicological Testing 1 03 
animal welfare movement, the classical LDso test (with a few specific exceptions) 
appears to be on its way out as a regulatory requirement. For example, the German 
authorities are accepting acute toxicity test data using small number of  animal^^^.^^ 
and the Food and Drug Administration has now explicitly stated that it has no 
requirement for LDSO tests and that acute toxicity data from alternative tests may 
well be acceptab~e.~~ 
The alternatives that are being considered all require the use of far fewer animals. 
~ r u c e ~ '  has proposed the use of six to ten animals in the Up-Down methodJ6 although 
it cannot be recommended fbr testing materials where delayed deaths (more than a 
few days) are the rule. Several simplifications of the standard method, all of which 
require fewer animals, have recently been proposed3740 and the last,"' which 
recommends the use of only 13 animals, is claimed to be suitable for industrial use 
where a variety of chemicals of widely differing toxicities must be assessed. Where 
only an estimate is required, the method proposled by Deichmann and LeBlanc offers 
yet another ~hoice.~'  
Another approach which has also been suggested, is the use of a structure-activity 
computer model to e ~ t i m a t e ~ ~ . ~ ~  LDm1s. This approach has been criticized because 
the chemicals used to design the models were not congeneric and because the biological 
end-point (death) used is not the function of a single active site in a well-defined 
system.44 The developers of the model argue that there is no question that the use of 
a congeneric set of chemicals would produce tighter estimates but that this is insufficient 
reason not to explore a model based on heterogenous collections of chemicals. As 
this field of quantitative structure-toxicity relationships (QSTR) develops, one can 
anticipate major strides in the use of these systems as predictors of toxicity.45 
There have been several papers which have correlated the results of cytotoxicity 
assays with LD5{s, but the development of an adequate cell culture 
alternative is very unlikely. There are many different toxic effects, and a crude 
cytotoxicity assay is unlikely to be successful as a general screen for acute toxicity. 
In addition, these non-mechanistic tests may result in the identification of an excessive 
number of false-positives and false-negatives and efforts to correlate cytotoxicity data 
with questionable LDS0 figures are unlikely to yield significant toxicological insights. 
Nevertheless, there is a clear need for good cytotoxicity data and for the development 
of reliable measures of  t to to xi city.^^-^^ 
Therefore, the present state of development of alternative approaches to the 
classical LDSO test is focused on the use of fewer animals (up to a 90 per cent reduction) 
with more attention being paid to morbidity and symptoms than a statistical estimate 
of the median lethal dose. For most purposes, the use of small numbers of animals 
to estimate the median lethal dose appears to be a satisfactory alternative. Cell culture 
systems have been investigated but they cannot provide the breadth of coverage of 
possible toxic insults of a simple in vivo mammalian organism. A computer model 
for estimating LDS{s has been developed.42 While it allows one to estimate the toxicity 
of a new substance quickly, the computer model suffers limitations as a possible 
replacement to the animal test. 
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2.1.2 Ophthalmic irritancy testing 
The classic method for assessing the potential for opthalmic irritancy of chemicals 
is the Draize Eye Imtancy t e ~ t . ~ ' * ~ *  In recent years this test has been criticized by 
both  scientist^^^.^ and by animal welfare groups." In fact, in 1978, Smyth commented 
that the Draize Eye Irritancy test was one area where a search for a non-animal 
alternative had a real chance of success.% A recent review of eye irritation testing 
outlines some of the difficulties in identifying eye irritants and the specific historical 
background of, and problems with the Draize Eye Irritancy tesLS7 For example, one 
of the main difficulties with this test as a regulatory tool is identified as the subjective 
nature of scoring and evaluating the test response. 
Pressure from animal welfare campaigns has, in recent years, resulted in the 
support of a number of projects to seek an alternative to the Draize Eye Irritancy 
test with promising results. The projects can be divided into those investigating 
modifications of the test which would result in less animal distress., and those 
investigating in vitro and protozoan systems as possible replacements.* 
(i) Refinements to the classical draize eye irritancy test: The test modifications 
which have been proposed include the use of smaller volumes:4 which would reduce 
the severity of the reaction as well as permitting the investigator to develop 
dose-response curves, the use of local  anaesthetic^,'^ an exfoliative cytology test which 
is reportedly more sensitive and more easily quantified than the classic Draize Eye 
Irritancy test,58 and the identification of all severe dermal irritants as eye irritants 
without further testing. =ffith and his colleagues have argued, with some justification, 
that the use of a single 100 pl aliquot for eye irritation testing is inappropriate. They 
suggest that a 10 pl aliquot (and higher multiples) is retained in the eye better and 
that dose-response curves can be developed if ne~essary.'~ In most cases, the use of 
smaller quantities of material being placed in the eye will result in less irritation and 
therefore less animal distress. 
In recent years, there have been several investigations of the use of local 
anaesthetics in the eye during ophthalmic testing as a means of reducing animal 
suffering. Ulsamer has reported that butacaine sulfate provided adequate anaesthesia 
without notably affecting the irritancy scores.59~oheisel (personal communication, 
1984) indicates that a double dose of tetracaine (separated by 10 minutes) is more 
effective in abolishing pain and interferes less with the initant response, although 
Walberg disputes this.S8 Johnson reports that amethocaine HCl is also effective. In a 
trial Of thirty one substances, the anaesthetic ether had no effect, or produced an 
increase in the irritant response and did not, therefore, mask irritan~y.~' 
Walberg has developed a very promising modification to the Draize Eye Irritancy 
test which is less stressful to the animal, more sensitive and more easily quantified." 
The eye is exposed to the test substances and then, at standard intervals after the 
exposure, exfoliated cells are retrieved from the conjunctival sac via a distilled water 
rinse. The number of cells retrieved is a very sensitive index of imtancy and correlates 
well with published Draize Eye Irritancy test scores. The approach needs further 
validation but appears to be promising as a more sensitive and more objective approach 
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to eye irritancy testing. The greater sensitivity of the exfoliative cytology test also 
means that smaller or more dilute doses of irritant substances could be used, thereby 
causing less trauma and distress. 
It has also been suggested that a rapid and simple approach to the elimination 
of most severe irritants from eye testing, and to reduce the number of rabbits required, 
would be to pre-test materials for primary skin irritation or other properties. However, 
williams6' reports that of 60 materials that were found to be severe primary skin 
irritants or corrosive to the skin, and that has also been tested for primary eye irritancy, 
only 34 were severe eye irritants. Fifteen of the 60 were only mildly irritating or 
non-irritants in the eye test. Williams cautions, therefore, that it may be misleading 
to classify a substance as an eye irritant solely on the basis of dermal irritancy. He 
suggests that the 24 hour occlusion method used in skin testing may well overwhelm 
physiological defence mechanisms. The lack of correlation between dermal and 
ophthalmic scores may be due to overestimation of the dermal response by current 
test procedures. In regards to other properties such as pH, substances with a pH of 
12 or more are usually regarded as eye irritants. However, Murphy and ~ o l l e a g u e s ~ ~  
caution that there is no simple rule for predicting irritancy from the pH. Acetic acid 
(5 percent), with a pH of 2.7, produces substantial corneal opacity while 0.3 percent 
hydrochloric acid (pH of 1.3) causes no corneal opacity. At the other end of the scale, 
2.5 percent ammonium hydroxide (pH 11.8) produced corneal opacity while 0.3 percent 
sodium hydroxide (pH 12.8) did not. Nevertheless, ~ a l z ~ ~  reports a clear relation 
between irritation (oedematous reaction after intracutaneous injection) aind pH in a 
mouse skin test of tissue compatible buffers. Buffers with a pH of below 3 and above 
11.5 caused irritation. The boundary for the alkalis was very sharp. 
(ii) Replacement methodr for the classical Draize Eye Irritancy test:A wide range 
of in vitro and protozoan systems have been proposed as possible alternatives (at least 
as preliminary screens) for the Draize Eye Irritancy test.'~ardone and ~ r a d l a f l  have 
already reviewed many of these including the use of enucleated eyes (rabbit), human 
or rabbit corneal cell cultures, other types of cell cultures, and the chorioallantois of 
chick embryos. Some of the first attempts to devise a specific alternative to the Drazie 
Eye Irritancy test were undertaken in Britain using mouse64 or human buccal mucosa 
cells.6s The authors of both reports indicated that the in vitro approach showed promise 
but that much more work would be needed to develop and validate an adequate test 
system. While there have been a spate of recent research reports678 from investigators 
seeking an alternative to the Draize Eye Irritancy test, there is still no clear indication 
of which approach might be the most effective. 
Cytotoxicity and cell morphology studies appear to be the favoured approach but 
few of the studies have gone beyond a characterization of the in vitro system. Douglas 
and Spilman chose to develop a human ocular cell culture as an in vitro assay since 
it would retain species-specific and organ-specific characteristic^.^' They chose corneal 
tissue since corneal damage is the most heavily weighted in scoring damage in the 
Draize Eye Irritancy test. They further required that the test system should be practical 
for routine use and that the assay be based on ceil perturbations which are relevant 
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to in vivo irritation (e.g. 51Cr release, LDH release), uptake of AIB (a non-metabolized 
amino acid), and rhodamine uptake as an index of mitochondria1 function. Although 
the preliminary results from 51Cr release were promising, the project was unfortunately 
not completed. 
While Douglas and others have favoured the idea of using corneal cells to match, 
as far as is possible, organ-specific characteristics, ~orenfreund~l reports that cells 
from different organs and species appear to give very similar results, indicating that 
it may not be that important to match cell culture type with the target organ. The 
results of Borenfreund's cytotoxicity and morphology assay indicate reasonable 
correlation with Draize Eye Imtancy test scores and also with another possible 
alternative based on a cellular uridine-transport assay developed in the same 
labora t~ry .~  
Another approach has involved the use of whole enucleated rabbit@ or bovine77 
eyes. Burton et al. report that the enucleated eyes remain viable for at least four 
hours and that there is good correlation of the results from this system (using a 
measurement of corneal swelling) with in vivo eye i~r i tancy .~~ However, although 
these whole eye systems may be useful as predictors of human eye imtation. Douglas 
argues that they are poorly suited to the screening of a large number of compounds 
or of many replicate samples.'' 
It has been suggested that cell culture systems are not well suited to predicting 
how fast the eye might recover from the toxic insult. However, Chan67 is working 
with a corneal cell culture system which might be used to predict recovery from injury 
and Jumblatt and ~ e u f e l d t ~ ~  have described a cell culture model for wound closure 
studies. 
Two other in vitro models using the chick chorioallantoic membranen (CAM) 
and excised guinea pig ileum73974 have also been reported recently. Leighton is 
developing the CAM from the chick embryo as a non-sentient but intact organ whicb 
could be used to evaluate irritation and inflarnmati~n.~ The initial reports are based 
on tests conducted with fairly strong acid and alkali solutions and measurement of 
the size of the resultant lesion. This is an end-point which requires refinement. There 
have also been problems from background imtation caused by shell fragments falling 
on the CAM when the aperture is cut. Nevertheless, the CAM system could be a 
very promising model for modelling inflammatory responses provided a simple but 
elegant end-point can be developed. 
Many new model systems have been investigated in the past few years and some 
already show considerable promise as improvements on the Draize Eye Irritancy test 
or as the basis for rapid screening systems, However, at the present time, none of 
the in vitro systems have yet been sufficiently validated or evaluated to be considered 
as replacements to the classical or modified Draize Eye Irritancy test. 
2.1.3 Dermal toxicity testing 
Some of the same approaches applied to the search for alternatives to ophthalmic 
imtancy testing would probably be successful for dermal irritancy testing. There are 
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difficulties in extrapolating from animal to humans.*.8' However, very little research 
into possible in vitro systems for identifying skin irritants has, so far, been undertaken. 
There have been isolated reports of the use of in vitro skin cultures to study toxic 
reactions or  mechanism^^^^^^ but there has been no concerted programme to seek an 
in vitro screening test for irritancy and cutaneous toxicity. Another area of dermal 
toxicity is phototoxicity which is now routinely evaluated in animals. several alternative 
methods have been investigatedg4-" but are still at a relatively early stage of 
development. 
2.1.4 Other organs 
One area of acute toxicity where alternative methods may be expected to 
contribute to our understanding of potential chemical insult concerns the atute 
reactions of isolated organs or cell cultures to large doses such as might occur during 
unintentional exposures. The setting of public emergency limits and the development 
of appropriate therapies for acute poisoning cases could find data derived from in 
vitro organotypic systems to be invaluable. Little attention has been paid to this area 
of acute organ toxicity. 
2.2 Chronic Toxicity Testing 
In chronic toxicity testing, where the investigator is assessing the likelihood for 
both targetted (for example, carcinogenicity) and non-targetted (for example, disorder 
in lipid metabolism) effects, we are much more likely to be able to predict human 
hazards if we understand the mechanism af the toxic insult than if we continue to rely 
on empirical testing approaches. In the acute toxicity field discussed above, there has 
been a focused, funded effort to find alternatives following both empirical, and 
mechanistic lines. In chronic toxicity testing, a similar effort is underway to develop 
short-term tests to identify mutagens, carcinogens and teratogens, but not to investigate 
organ-specific effects. 
3. CONCLUSION 
This brief review of alternative approaches to acute toxicity tests and eye irritancy 
testing provides an introduction to some new conceptual approaches to toxicology 
testing. A simple empirical search for in vitro tests that correlate with various toxic 
ehd-points will not only be insufficient, it will be detrimental. The possibility of 
developing superior methods for safety evaluation is much more likely to be realized 
if mechanistic approaches are used when investigating in vim tests. For cell cultures, 
both animal and human, to be used to their full potential, the culture techniques must 
be considerably improved. Fully defined growth media must be developed which will 
support the growth of a wide range of defined cells. It is now possible to maintain 
and grow many different types of cells which express differentiated function in vim. 
For example, changing culture conditions allowed one group of investigators to 
establish a thyroid cell line which expressed differentiated thyroid cell characteristics 
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even after three years of continuous c~lture. '~ Also, beating heart cells can be 
maintained for a week in good condition and have been used to investigate anaestheticg9 
and isoproterenolgO cardiotoxicity. 
Computer-assisted structue-activity relationships in toxicology have not yet been 
\ developed. As toxicology databases and our understanding of mechanisms improve, 
so will the potential applicability of quantitative structure-toxicity relationship^."^^^^^ 
With the exciting advances now taking place in the disciplines that contribute to 
toxicology (for example,molecular biology, cell biology), the time is opportune for 
academic, industrial and regulatory toxicologists to explore new avenues for safety 
evaluation. This will mean discarding tests which no longer do what they are meant 
to and developing new ones which provide better assessments of potential human 
hazards. 
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